Current options for the management of rectal cancer (Q37052720)

17 August 2017

1 reference

title

Current options for the management of rectal cancer (English)

1 reference

17 August 2017

Bert H O'Neil

1

1 reference

PubMed ID

18181024

17 August 2017

Joel E Tepper

series ordinal

2

1 reference

17 August 2017

1 October 2007

1 reference

Current Treatment Options in Oncology

17 August 2017

1 reference

17 August 2017

8

1 reference

17 August 2017

5

1 reference

17 August 2017

331-338

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-007-0048-7

17 August 2017

0 references

cites work

Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-007-0048-7

Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-007-0048-7

Dose response to preoperative irradiation in rectal cancer: implications for local control and complications associated with sphincter sparing surgery and abdominoperineal resection

21 January 2018

1 reference

12 December 2020

Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection

1 reference

12 December 2020

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

12 December 2020

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.

1 reference

12 December 2020

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

12 December 2020

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy. A report of a phase I-II trial

1 reference

12 December 2020

Major or local surgery for cure in early rectal and sigmoid carcinoma--a prospective evaluation

1 reference

12 December 2020

Total rectal resection and colo-anal anastomosis for low rectal tumours: comparative results in a group of young and old patients.

1 reference

12 December 2020

Analysis of Surgical Salvage After Failure of Primary Therapy in Rectal Cancer: Results From Intergroup Study 0114

1 reference

12 December 2020

Colorectal cancer with synchronous liver metastases

1 reference

12 December 2020

Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases

1 reference

12 December 2020

Conservative management of invasive rectal cancer: alternative to abdominoperineal resection.

1 reference

12 December 2020

Clarifying margins in the multidisciplinary management of rectal cancer: the MERCURY experience.

1 reference

12 December 2020

Adjuvant therapy for colorectal cancer: yesterday, today, and tomorrow

1 reference

12 December 2020

Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study

1 reference

12 December 2020

Selection criteria for local excision with or without adjuvant radiation therapy for rectal cancer

1 reference

12 December 2020

A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer

1 reference

12 December 2020

Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study

1 reference

12 December 2020

Clinico-pathological features of prognostic significance in operable rectal cancer in 17 centres in the U.K. (Third report of the M.R.C. Trial, on behalf of the Working Party)

1 reference

12 December 2020

The multidisciplinary treatment of rectal cancer: pathology.

1 reference

12 December 2020

Recurrence and survival after total mesorectal excision for rectal cancer

1 reference

12 December 2020

CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.

1 reference

12 December 2020

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

12 December 2020

Imaging of rectal cancer

1 reference

12 December 2020

Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial

1 reference

12 December 2020

A pilot study of sphincter-sparing management of adenocarcinoma of the rectum

1 reference

12 December 2020

Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.

1 reference

12 December 2020

Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.

1 reference

12 December 2020

Nonoperative management of primary colorectal cancer in patients with stage IV disease

1 reference

12 December 2020

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

12 December 2020

Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study

1 reference

12 December 2020

The reality of radical sphincter preservation surgery for cancer of the distal 3 cm of rectum following high-dose radiation

1 reference

12 December 2020

The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation

1 reference

12 December 2020

The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer

1 reference

12 December 2020

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer

1 reference

12 December 2020

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

12 December 2020

Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis.

1 reference

12 December 2020

A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer

1 reference

12 December 2020

Prolongation of the disease-free interval in surgically treated rectal carcinoma

1 reference

12 December 2020

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

12 December 2020

Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database

1 reference

12 December 2020

Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer

1 reference

12 December 2020

Technique and results of transanal endoscopic microsurgery in early rectal cancer

1 reference

12 December 2020

10.1007/S11864-007-0048-7

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18181024